Sds Optic Spolka Akcyjna Logo

Sds Optic Spolka Akcyjna

Develops diagnostic solutions, custom antibodies, and optical coatings.

SDS | WAR

Overview

Corporate Details

ISIN(s):
PLSDSOP00013 (+3 more)
LEI:
259400G9MUCF7RQLHQ45
Country:
Poland
Address:
LUBLIN GŁĘBOKA 39, 20-612 LUBLIN

Description

Sds Optic Spolka Akcyjna is a biotechnology company that develops diagnostic solutions for oncology and infectious diseases. Its flagship technology, inPROBE®, is a fiber-optic microsensor that combines photonics and molecular biology for the real-time, point-of-care detection of cancer biomarkers, such as HER2 expression. This platform is designed to complement existing diagnostic methods to improve access to targeted therapies. In addition to its diagnostic focus, the company provides custom antibody development and small-scale manufacturing services, including monoclonal and anti-idiotype antibodies. Sds Optic also offers advanced optical coating solutions using nanolayer technology to enhance the performance and durability of lenses for the optics, electronics, and medical device industries.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-11-28 13:57
Informacja nt. rekomendowania dofinansowania projektu Spółki przez Lubelską Age…
Polish 3.2 KB
2023-10-02 08:41
Zawarcie umowy finansowania z Europejskim Bankiem Inwestycyjnym - Content (PL)
Polish 8.7 KB
2023-07-14 15:44
Informacja o wyroku sądu w sprawie postępowania wszczętego wobec Spółki dotyczą…
Polish 3.3 KB
2023-06-30 10:52
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 1.0 KB
2023-06-30 10:39
SDS_Optic_SA_ZWZA_Zalacznik1_Przyjete_Uchwaly.pdf
Polish 217.2 KB
2023-06-30 10:39
Treść uchwał podjętych podczas obrad Zwyczajnego Walnego Zgromadzenia w dniu 30…
Polish 621 bytes
2023-06-26 13:30
Rozpoczęcie realizacji nowego kamienia milowego przy współpracy z Philips i CSE…
Polish 6.0 KB
2023-06-15 12:35
Powiadomienie_Magdalena_Staniszewska_19_MAR.pdf
Polish 4.4 KB
2023-06-15 12:35
Powiadomienie_Marcin_Staniszewski_19_MAR.pdf
Polish 4.3 KB
2023-06-15 12:35
Informacja o transakcjach dokonanych przez osobę pełniącą obowiązki zarządcze o…
Polish 730 bytes
2023-06-02 09:07
SDS_Optic_SA_ZWZA_Zalacznik9_Regulamin_WZA.pdf
Polish 211.5 KB
2023-06-02 09:07
SDS_Optic_SA_ZWZA_Zalacznik8_Sprawozdanie_RN_za_2022r_31.5.2023_DocuSign.pdf
Polish 995.6 KB
2023-06-02 09:07
SDS_Optic_SA_ZWZA_Zalacznik7_Informacja_Liczba_Rodzaj_Akcji.pdf
Polish 92.7 KB
2023-06-02 09:07
SDS_Optic_SA_ZWZA_Zalacznik6_Klauzula_RODO.pdf
Polish 139.5 KB
2023-06-02 09:07
SDS_Optic_SA_ZWZA_Zalacznik5_Formularz_Glosowania_Pelnomocnik.pdf
Polish 313.9 KB

Automate Your Workflow. Get a real-time feed of all Sds Optic Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sds Optic Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sds Optic Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.